Back

Glycemic control with ipragliflozin, a novel selective SGLT2 inhibitor, ameliorated endothelial dysfunction in obese and non-obese diabetic mice.

29 August 2016 (15:42 - 15:49)
Organised by:
Congress Presentation Part of: Vascular biology Endothelial function ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Hotimah Masdan Salim

University of Nahdlatul Ulama Surabaya, Surabaya (Indonesia)

6 More presentations in this session

Presentation thumbnail
Myeloid cell specific alpha1-AMPK deletion induces a proinflammatory phenotype and enhances angiotensin II-mediated vascular dysfunction
Doctor T. Jansen (Mainz, DE)
Abstract
Presentation thumbnail
Endothelial PGC-1alpha preserves endothelial function during chronic angiotensin II treatment by maintaining eNOS expression, reducing vascular oxidative stress and supporting the antioxidant defense
Doctor T. Jansen (Mainz, DE)
Abstract
Presentation thumbnail
Impact of the adiponectin paralog CTRP13 on endothelial cells
Doctor M. Aslam (Giessen, DE)
Abstract
Presentation thumbnail
Monocyte-platelet aggregates associated with CD14++CD16+ monocytes predict diffuse coronary artery disease: relationship to microvascular function
Doctor R. Brown (Newcastle-Upon-Tyne, GB)
Abstract Slides
Presentation thumbnail
A direct thrombin inhibitor paradoxically enhances thrombin generation via suppression of protein C activation and factor Va degradation in human plasma
Doctor Y. Morishima (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
Vascular biology

The Event

Event poster

ESC Congress 2016

29 August 2016 15:42 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources